We are live on
!
Find out more
PFM
Privium Fund Management Portfolio holdings
AUM
$480M
1-Year Est. Return
77.45%
This Fund
S&P 500
This Quarter
Est. Return
+18.86%
1 Year Est. Return
+77.45%
3 Year Est. Return
+410.34%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$402M
AUM Growth
+$9.94M
(+2.5%)
Cap. Flow
-$18.6M
Cap. Flow
% of AUM
-4.62%
Top 10 Holdings %
Top 10 Hldgs %
65.74%
Holding
141
New
12
Increased
36
Reduced
12
Closed
59
Top Buys
| 1 |
AST SpaceMobile
ASTS
|
+$18.5M |
| 2 |
Occidental Petroleum
OXY
|
+$4.63M |
| 3 |
Merck
MRK
|
+$1.94M |
| 4 |
NVIDIA
NVDA
|
+$1.89M |
| 5 |
Moderna
MRNA
|
+$1.58M |
Top Sells
| 1 |
Occidental Petroleum Corp Warrants
OXY.WS
|
+$20.1M |
| 2 |
CrowdStrike
CRWD
|
+$5.88M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
+$4.8M |
| 4 |
Snowflake
SNOW
|
+$4.18M |
| 5 |
ASTSW
AST SpaceMobile, Inc. Warrant
ASTSW
|
+$3.71M |
Sector Composition
| 1 | Technology | 28.91% |
| 2 | Consumer Discretionary | 27.03% |
| 3 | Healthcare | 24.48% |
| 4 | Communication Services | 15.36% |
| 5 | Energy | 1.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Occidental Petroleum
OXY
$54.3B
| $4.18M | 1.04% |
+81,192
| New | +$4.63M |
|
27
uniQure
QURE
$2.85B
| $3.67M | 0.91% |
744,916
+104,500
| +16% | +$680K |
|
|
28
Moderna
MRNA
$26.8B
| $2.71M | 0.67% |
40,482
+17,221
| +74% | +$1.58M |
|
29
Acadia Pharmaceuticals
ACAD
$4.36B
| $2.28M | 0.57% |
148,400
| – | – |
|
30
Ambev
ABEV
$47.7B
| $1.52M | 0.38% |
622,314
-13,600
| -2% | -$30.5K |
|
31
CRISPR Therapeutics
CRSP
$4.97B
| $1.43M | 0.35% |
30,347
+3,000
| +11% | +$152K |
|
|
RNAM
32
DELISTED
Avidity Biosciences
RNAM
| $1.18M | 0.29% |
25,600
+3,358
| +15% | +$146K |
|
33
Krystal Biotech
KRYS
$10B
| $1.16M | 0.29% |
6,350
-70
| -1% | -$13.5K |
|
34
4D Molecular Therapeutics
FDMT
$612M
| $1.06M | 0.26% |
98,500
+58,500
| +146% | +$971K |
|
35
ALX Oncology
ALXO
$269M
| $926K | 0.23% |
509,059
+112,093
| +28% | +$417K |
|
36
MeiraGTx Holdings
MGTX
$1.15B
| $892K | 0.22% |
213,960
+10,000
| +5% | +$43.2K |
|
37
Citigroup
C
$227B
| $802K | 0.2% |
12,804
+326
| +3% | +$20.2K |
|
38
Franco-Nevada
FNV
$39.1B
| $753K | 0.19% |
6,061
+3,691
| +156% | +$457K |
|
|
AUTL
39
Autolus Therapeutics
AUTL
$386M
| $674K | 0.17% |
185,639
+25,000
| +16% | +$99.7K |
|
40
Pfizer
PFE
$138B
| $636K | 0.16% |
21,978
-14,142
| -39% | -$413K |
|
41
NOV
NOV
$6.93B
| $606K | 0.15% |
37,925
-1,794
| -5% | -$31.9K |
|
42
American International
AIG
$41.9B
| $588K | 0.15% |
8,024
-465
| -5% | -$34.7K |
|
43
Peabody Energy
BTU
$2.93B
| $561K | 0.14% |
21,140
+5,900
| +39% | +$134K |
|
44
Pan American Silver
PAAS
$18.3B
| $553K | 0.14% |
26,484
+3,500
| +15% | +$73.8K |
|
|
AZEK
45
DELISTED
The AZEK Co
AZEK
| $541K | 0.13% |
11,550
+2,950
| +34% | +$126K |
|
46
Dyne Therapeutics
DYN
$3.93B
| $539K | 0.13% |
15,016
+1,000
| +7% | +$39.8K |
|
|
SA
47
Seabridge Gold
SA
$2.78B
| $539K | 0.13% |
32,087
+4,253
| +15% | +$69.2K |
|
48
Recursion Pharmaceuticals
RXRX
$1.77B
| $514K | 0.13% |
78,000
+26,000
| +50% | +$186K |
|
49
Interface
TILE
$1.91B
| $508K | 0.13% |
+26,800
| New | +$462K |
|
50
Valaris
VAL
$5.44B
| $424K | 0.11% |
7,611
-523
| -6% | -$34.3K |
|
Similar funds
FCM
DA
YLHM
BFA
HC
LIM
TAA
NQWM